The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Domperidone: A Peripherally Acting Dopamine2-Receptor Antagonist
Abstract
OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, and safety of domperidone in the treatment of gastrointestinal motility disorders and emesis. DATA SOURCES: MEDLINE and Excerpta Medica online databases were searched to identify published reports. STUDY SELECTION: Domperidone has been marketed worldwide outside the US since 1978, and extensive clinical data for this drug are available. This review focuses on the clinical experience from controlled studies of domperidone in the treatment of motility disorders, particularly diabetic gastroparesis. Also, case reports are used in summarizing safety. The control comparator groups included placebo or other prokinetic drugs (metoclopramide and cisapride). Controlled clinical trials of domperidone's efficacy and safety as an antiemetic are also briefly examined. Although a variety of domperidone dosage forms have been marketed, data generated from trials using the 10-mg tablet are highlighted because this is the only dosage form available in Canada and is under investigation in the US. DATA EXTRACTION: Because symptoms do not correlate with objective measures of gastrointestinal motility and they are the primary reason that patients with motility disorders seek treatment, the primary outcome extracted from the clinical studies was symptomatic response to treatment. Safety and efficacy between domperidone and placebo, metoclopramide, or cisapride were compared. DATA SYNTHESIS: Domperidone, a peripheral dopamine 2-receptor antagonist, regulates the motility of gastric and small intestinal smooth muscle and has been shown to have some effects on the motor function of the esophagus. It also has antiemetic activity as a result of blockade of dopamine receptors in the chemoreceptor trigger zone. In controlled clinical trials, domperidone provided better relief of symptoms (anorexia, nausea, vomiting, abdominal pain, early satiety, bloating, distension) than placebo in patients with symptoms of diabetic gastropathy; symptomatic improvement was similar with domperidone and metoclopramide or cisapride. Domperidone also provided short-term relief of symptoms in patients with dyspepsia or gastroesophageal reflux, prevented nausea and vomiting associated with emetogenic chemotherapy, and prevented the gastrointestinal and emetic adverse effects of antiparkinsonian drugs. Because very little domperidone crosses the blood–brain barrier, reports of central nervous system adverse effects, such as dystonic reactions, are rare. CONCLUSIONS: Domperidone is a unique gastrokinetic and antiemetic drug. Because of its favorable safety profile, domperidone appears to be an attractive alternative to metoclopramide. In the management of diabetic gastropathy, domperidone's antiemetic activity distinguishes it from cisapride.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Laduron, P. M., & Leysen, J. E. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90198-9 · Cited by 396
Metoclopramide: Pharmacology and Clinical Application
ALBIBI, R., & McCALLUM, R. W. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-86 · Cited by 348
Koch, K. L., Stern, R. M., Stewart, W. R., & Vasey, M. W. (1989) · PubMed · Cited by 324
Metoclopramide: Pharmacology and clinical application
Bullard, D. E. (1983) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(83)90196-9 · Cited by 295
Brogden, R. N., Carmine, A. A., Heel, R. C., Speight, T. M., & Avery, G. S. (1982) · Drugs · doi:10.2165/00003495-198224050-00002 · Cited by 280
Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy
Horowitz, M., Harding, P. E., Chatterton, B. E., Collins, P. J., & Shearman, D. J. C. (1985) · Digestive Diseases and Sciences · doi:10.1007/bf01318363 · Cited by 236
GARDINER, P. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91078-7 · Cited by 228
Dopamine as A Possible Neurotransmitter in Gastric Relaxation
Valenzuela, J. E. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80051-0 · Cited by 205
Hughes, A. J., Bishop, S., Kleedorfer, B., Turjanski, N., Fernandez, W., Lees, A. J., & Stern, G. M. (1993) · Movement Disorders · doi:10.1002/mds.870080208 · Cited by 204
Disordered gastric motor function in diabetes mellitus
Horowitz, M., & Fraser, R. (1994) · Diabetologia · doi:10.1007/bf00403371 · Cited by 178
Gastrointestinal Transit Disorders in Patients with Insulin-Treated Diabetes mellitus
Wegener, M., Börsch, G., Schaffstein, J., Luerweg, C., & Leverkus, F. (2008) · Digestive Diseases · doi:10.1159/000171237 · Cited by 116
Heykants, J. J. P., Hendriks, R., Meuldermans, W., Michiels, M., Scheygrond, H., & Reyntjens, H. (1981) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189516 · Cited by 109
Agid, Y., Bonnet, A. M., Pollak, P., Signoret, J. L., & Lhermitte, F. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91003-1 · Cited by 103
Prokinetic agents for lower gastrointestinal motility disorders
Longo, W. E., & Vernava, A. M. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02238599 · Cited by 102
Horowitz, M., Edelbroek, M. A. L., Fraser, R. J., Maddox, A. F., & Wishart, J. M. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998583 · Cited by 96
Gastrointestinal motility disorders in patients with diabetes mellitus
Abrahamsson, H. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01194.x · Cited by 88
Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine
Fritsch, C. M., Simon-Assmann, P. M., Kédinger, M., & EVANS, G. S. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041244 · Cited by 81
Domperidone, a new dopamine antagonist.
Champion, M. C., Hartnett, M. N., & Yen, M. (1986) · PubMed · Cited by 78
Dopamine regulation of [3H]acetylcholine release from guinea-pig stomach.
Kusunoki, M., Taniyama, K., & Tanaka, C. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23692-8 · Cited by 78
Teething complications, a persisting misconception
Swann, I. (1979) · Postgraduate Medical Journal · doi:10.1136/pgmj.55.639.24 · Cited by 70
Grill, B. B., Hillemeier, A. C., Semeraro, L. A., McCallum, R. W., & Gryboski, J. D. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80315-2 · Cited by 64
Domperidone and levodopa in Parkinson's disease.
Shindler, J. S., Finnerty, G. T., Towlson, K. E., et al. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02571.x · Cited by 62
Review of the current status of prokinetic agents in gastroenterology.
McCallum, R. W. (1985) · PubMed · Cited by 62
Bromocriptine and domperidone in the treatment of Parkinson disease
Quinn, N. P., Illas, A., Lhermitte, F., & Agid, Y. (1981) · Neurology · doi:10.1212/wnl.31.6.662 · Cited by 60
Meuldermans, W., Hurkmans, R., Swysen, E., Hendrickx, J., Michiels, M., Lauwers, W., & Heykants, J. J. P. (1981) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189515 · Cited by 59
Domperidone; secretion in breast milk and effect on puerperal prolactin levels
Hofmeyr, G. J., Iddekinge, B. V., & Blott, J. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01065.x · Cited by 56
Weihrauch, T. R., Förster, C. F., & Krieglstein, J. (1979) · PubMed · Cited by 56
Sublingual Apomorphine in Parkinsonʼs Disease
Montastruc, J. L., Rascol, O., Sénard, J., et al. (1991) · Clinical Neuropharmacology · doi:10.1097/00002826-199110000-00007 · Cited by 54
Dopamine antagonists in the upper gastrointestinal tract.
Valenzuela, J. E., & Dooley, C. P. (1984) · PubMed · Cited by 53
Sowers, J. R., Sharp, B. M., & McCallum, R. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-4-869 · Cited by 53
de Loore, Van Ravensteyn, H., & Ameryckx, L. (1979) · PubMed · Cited by 53
Prokinetic Agents: A Key in the Future of Gastroenterology
Reynolds, J. C. (1989) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00686-5 · Cited by 52
Oral Domperidone in Chronic Postprandial Dyspepsia
de Mierop, L. V., Rutgeerts, L. J., den Langenbergh, B. V., & Staessen, A. J. (2009) · Digestion · doi:10.1159/000198352 · Cited by 52
Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying.
Bekhti, A., & Rutgeerts, L. J. (1979) · PubMed · Cited by 51
Diabetic Gastroparesis: A Critical Reappraisal of New Treatment Strategies
Drenth, J. P. H., & Engels, L. G. J. B. (1992) · Drugs · doi:10.2165/00003495-199244040-00002 · Cited by 49
Domperidone, Metoclopramide, and Placebo
Maddern, G. J., Kiroff, G., Leppard, P., & Jamieson, G. G. (1986) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198604000-00006 · Cited by 48
Intranasal Apomorphine in Parkinsonian On-Off Fluctuations
van Laar, T., Jansen, E. N. H., Essink, A. W. G., & Neef, C. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290064013 · Cited by 47
Extra-cranial aneurysm of the internal carotid artery treated by proximal ligation
Haywood, I. R., & Ellis, H. (1979) · Postgraduate Medical Journal · doi:10.1136/pgmj.55.639.30 · Cited by 47
Pharmacokinetics and Dose Proportionality of Domperidone in Healthy Volunteers
Huang, Y., Colaizzi, J. L., Bierman, R. H., Woestenborghs, R. J. H., & Heykants, J. (1986) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1986.tb02962.x · Cited by 45
Outryve, M. V., NUTTE, N. D., Eeghem, P. V., & Jp, G. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098328 · Cited by 45
Tatsuta, M., Iishi, H., Nakaizumi, A., & Okuda, S. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00265.x · Cited by 44
MASCI, E., Testoni, P. A., Passaretti, S. M., Guslandi, M., & Tittobello, A. (1985) · PubMed · Cited by 40
Michiels, M., Hendriks, R., & Heykants, J. J. P. (1981) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189514 · Cited by 40
Hofmeyr, G. J., & Iddekinge, B. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91818-4 · Cited by 39
Nagler, J., & Miskovitz, P. F. (1981) · PubMed · Cited by 38
Sanger, G. J. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb05108.x · Cited by 37
Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
Brown, C. P., & Khanderia, U. (1990) · PubMed · Cited by 31
Apomorphine in the Diagnosis and Treatment of Parkinsonian Tremor
Hughes, A. J., Lees, A. J., & Stern, G. M. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199008000-00005 · Cited by 30
Haarmann, K., Lebküchner, F., Widmann, A., Kief, W., & Esslinger, M. (1979) · PubMed · Cited by 28
Domperidone in the Treatment of Dyspepsia: A Double-Blind Placebo-Controlled Study
Arts, E., Anthoni, H., de Roy, G., et al. (1979) · Journal of International Medical Research · doi:10.1177/030006057900700208 · Cited by 27
Baeyens, R., Van de Velde, E., De Schepper, A., Wollaert, F., & Reyntjens, A. J. M. (1979) · PubMed · Cited by 27
Acute extrapyramidal dysfunction after domperidone administration. Report of a case.
Franckx, J., & Noel, P. (1984) · PubMed · Cited by 25
Clinical trial on the effect of domperidone on non-ulcer dyspepsia.
Sarin, S. K., Sharma, P. K., Chawla, Y. K., Gopinath, P., & Nundy, S. (1986) · PubMed · Cited by 22
Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting.
M, V. O., Lauwers, W., & Verbeke, S. B. (1979) · PubMed · Cited by 22
Comparison of Levodopa with Carbidopa, and Levodopa with Domperidone in Parkinsonʼs Disease
Langdon, N., Malcolm, P. N., & Parkes, J. D. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198610000-00004 · Cited by 22
Parkinsonism and Tardive Dyskinesia Associated with Long-Term Metoclopramide Therapy
Grimes, J. D. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052316 · Cited by 22
Domperidone‐induced acute dystonia and polycystic ovary syndrome
Bonuccelli, U., Nocchiero, A., Napolitano, A., Paoletti, A. M., Melis, G. B., Corsini, G. U., & MURATORIO, A. (1991) · Movement Disorders · doi:10.1002/mds.870060116 · Cited by 20
The effect of domperidone on oesophageal emptying in diabetic autonomic neuropathy.
Maddern, G. J., Horowitz, M., & Jamieson, G. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02668.x · Cited by 18
Double-Blind Evaluation of Domperidone in Acute Vomiting and Dyspeptic Disorders
Agorastos, I., Zissis, N. P., Kaprinis, I., & Goulis, G. (1981) · Journal of International Medical Research · doi:10.1177/030006058100900211 · Cited by 17
Diabetic gastroparesis: A review
Kinsley, B., Gramm, H. F., & Rolla, A. R. (1991) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(91)90078-4 · Cited by 16
De Schepper, A., Wollaert, F., & Reyntjens, A. J. M. (1978) · PubMed · Cited by 11
Galactorrhoea due to domperidone
Maddern, G. J. (1983) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1983.tb122658.x · Cited by 9
Effect of metoclopramide, domperidone and apomorphine on GH secretion in children and adolescents
MASSARA, F., Tangolo, D., Godano, A., GOFFI, S., Bertagna, A., & Molinatti, G. M. (1985) · European Journal of Endocrinology · doi:10.1530/acta.0.1080451 · Cited by 8
The effects of domperidone on the absorption of levodopa in normal subjects
Bradbrook, I. D., Gillies, H., Morrison, P. J., et al. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00615966 · Cited by 8
The GI drug column. Subcommittee on FDA related matters, American College of Gastroenterology.
Friedman, G. (1983) · PubMed · Cited by 5
The effect of domperidone on theophylline disposition in the rat
Bawazir, S. A., Al-Hassan, M. I., Matar, K. M., & Tekle, A. (1989) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510100602 · Cited by 4
Cited by
Tonini, M., Cipollina, L., Poluzzi, E., Crema, F., Corazza, G. R., & De Ponti, F. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01867.x · Cited by 291
Li, Z. S., Schmauss, C., Cuenca, A., Ratcliffe, E., & Gershon, M. D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4720-05.2006 · Cited by 276
Bharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s106284 · Cited by 138
A Systematic Review of the Efficacy of Domperidone for the Treatment of Diabetic Gastroparesis
Sugumar, A., Singh, A., & Pasricha, P. J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.065 · Cited by 102
Metadata
- Authors
- Barone, J. A.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 1999-04
- Volume
- 33
- Issue
- 4
- Pages
- 429-440
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2164198919
- Cited by
- 259
- References
- 67
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.